Stimulation | Top biological functions | # genes4 | Fisher p-value |
---|---|---|---|
LPS | Cellular Growth and Proliferation2 | 126/2404 | 2.25E-18 - 7.17E-07 |
 | Cell Death2 | 114/2259 | 2.00E-27 - 9.59E-07 |
 | Immunological Disease1 | 113/1730 | 3.40E-46 - 9.59E-07 |
 | Immune Response3 | 113/475 | 6.00E-23 - 9.56E-07 |
 | Inflammatory Disease1 | 108/401 | 2.58E-45 - 1.06E-06 |
 | Hematological System Development and Function3 | 101/1446 | 6.70E-28 - 8.53E-07 |
 | Cell-To-Cell Signaling and Interaction2 | 99/1465 | 2.44E-24 - 4.29E-07 |
 | Cellular Movement2 | 92/1364 | 6.70E-28 - 8.33E-07 |
 | Immune and Lymphatic System Development and Function3 | 92/430 | 3.43E-19 - 8.03E-07 |
 | Skeletal and Muscular Disorders1 | 83/2024 | 2.52E-39 - -2.26E-07 |
 | Cellular Development2 | 82/1899 | 1.66E-15 - 1.08E-06 |
 | Connective Tissue Disorders1 | 80/145 | 2.52E-39 - -2.26E-07 |
 | Tissue Morphology3 | 73/943 | 4.02E-20 - 8.53E-07 |
 | Tissue Development3 | 68/1374 | 6.06E-18 - 5.30E-07 |
 | Infectious Disease1 | 63/1087 | 1.60E-32 - 1.08E-06 |
PMA/ionomycin | Cancer1 | 913/2395 | 5.41E-25 - 5.07E-08 |
 | Cellular Growth and Proliferation2 | 826/2404 | 3.15E-48 - 1.18E-08 |
 | Cell Death2 | 725/2259 | 1.10E-32 - 5.07E-08 |
 | Cellular Development2 | 491/1899 | 3.61E-32 - 4.90E-08 |
 | Hematological System Development and Function3 | 481/1446 | 1.34E-35 - 4.73E-08 |
 | Immune Response3 | 451/475 | 1.34E-35 - 4.73E-08 |
 | Immunological Disease1 | 433/1730 | 1.83E-52 - 3.92E-08 |
 | Immune and Lymphatic System Development and Function3 | 415/430 | 1.34E-35 - 2.91E-08 |
 | Inflammatory Disease1 | 377/401 | 5.57E-36 - 4.26E-09 |
 | Cell Cycle2 | 360/1017 | 4.35E-26 - 4.78E-08 |
 | Skeletal and Muscular Disorders1 | 327/2024 | 5.57E-36 - 3.41E-08 |
 | Tissue Morphology3 | 313/943 | 1.10E-32 - 2.30E-08 |
 | Connective Tissue Disorders1 | 294/145 | 5.57E-36 - 5.29E-09 |
 | Organismal Survival3 | 290/971 | 1.10E-15 - 2.41E-08 |
 | Protein Synthesis2 | 242/534 | 1.30E-29 - 6.66E-09 |